Comparative efficacy: what we know, what we need to know, and how we can get there.
Malozowski
Saul
S
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D017277:Drug Approval; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D012107:Research Design / Q000592:standards*; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration
D050071:Bone Density Conservation Agents